(3-285) A Review of the Safety and Efficacy of Long-Acting Cabotegravir Intramuscular Injection for Human Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis
Monday, December 5, 2022
12:00 PM – 1:00 PM
Location: Bayside A, Level 1
Category: Evaluative Study Topic: Infectious Diseases/HIV